Literature DB >> 10505425

Hyperthyroidism is associated with preserved preconditioning capacity but intensified and accelerated ischaemic contracture in rat heart.

C I Pantos1, D D Cokkinos, S M Tzeis, V Malliopoulou, I S Mourouzis, H C Carageorgiou, C Limas, D V Varonos, D V Cokkinos.   

Abstract

BACKGROUND: The present study was undertaken to define the effects of thyroxine administration on ischaemic preconditioning (PC) and the ischaemic contracture.
METHODS: Hyperthyroidism was induced by administration of L-thyroxine in rats (THYR) while normal animals served as controls (NORMa). Isolated rat hearts were perfused in a Langendorff preparation. NORMa control (n = 16) and THYR control (n = 9) hearts underwent 20 min of ischaemia and 45 min reperfusion while NORMa PC (n = 16) and THYR PC (n = 14) were subjected to PC before ischaemia. Additional normal hearts were subjected to 30 min of ischaemia with and without PC, NORMb control, n = 8 and NORMb PC, n = 6. Postischaemic recoveries of left ventricular (LV) developed pressure were expressed as % of the initial value (LVDP%). Severity of contracture was measured by the time (Tmax) and magnitude (Cmax) of peak contracture.
RESULTS: LVDP% was significantly higher after PC, both in NORMa and THYR rats. In NORMa control hearts, ischaemic contracture had not yet reached a plateau at 20 min of ischaemia. Contracture appeared earlier in THYR control and PC than in NORMa control and PC groups. Tmax was 22.1 (0.9) vs 16.8 (1.4) min for NORMb control and PC, p < 0.05 and 12.5 (1.0) vs 9.3 (1.1) min for THYR control and PC hearts, p < 0.05. Tmax was earlier in both THYR groups compared to NORMb groups, p < 0.05. Cmax was significantly higher in both THYR groups compared to both NORMb groups.
CONCLUSION: Ischaemic contracture is both accelerated and accentuated in thyroxine treated hearts while preconditioning capacity is preserved. Preconditioning and thyroxine administration shorten Tmax in an additive way, whereas Cmax in hyperthyroid hearts did not further increase by preconditioning.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10505425     DOI: 10.1007/s003950050150

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  6 in total

1.  Changes in antioxidant status, protein concentration, acetylcholinesterase, (Na+,K+)-, and Mg2+ -ATPase activities in the brain of hyper- and hypothyroid adult rats.

Authors:  Haris Carageorgiou; Constantinos Pantos; Apostolos Zarros; Iordanis Mourouzis; Dennis Varonos; Dennis Cokkinos; Stylianos Tsakiris
Journal:  Metab Brain Dis       Date:  2005-06       Impact factor: 3.584

2.  Thyroid hormone and cardioprotection: study of p38 MAPK and JNKs during ischaemia and at reperfusion in isolated rat heart.

Authors:  Constantinos Pantos; Vassiliki Malliopoulou; Ioannis Paizis; Panagiotis Moraitis; Iordanis Mourouzis; Stylianos Tzeis; Evangelia Karamanoli; Demosthenes D Cokkinos; Hariclia Carageorgiou; Dennis Varonos; Dennis V Cokkinos
Journal:  Mol Cell Biochem       Date:  2003-01       Impact factor: 3.396

3.  Effects of hyper- and hypothyroidism on acetylcholinesterase, (Na(+), K (+))- and Mg ( 2+ )-ATPase activities of adult rat hypothalamus and cerebellum.

Authors:  Haris Carageorgiou; Constantinos Pantos; Apostolos Zarros; Vasileios Stolakis; Iordanis Mourouzis; Dennis Cokkinos; Stylianos Tsakiris
Journal:  Metab Brain Dis       Date:  2006-12-14       Impact factor: 3.584

Review 4.  New insights into the role of thyroid hormone in cardiac remodeling: time to reconsider?

Authors:  Constantinos Pantos; Iordanis Mourouzis; Dennis V Cokkinos
Journal:  Heart Fail Rev       Date:  2011-01       Impact factor: 4.214

5.  Loss of cardioprotection induced by ischemic preconditioning after an initial ischemic period in isolated rat hearts.

Authors:  Alexandros D Cokkinos; Stylianos Tzeis; Panagiotis Moraitis; Constantinos Pantos; Hariklia Carageorgiou; Dimitrios Panousopoulos; Dennis D Varonos; Dennis V Cokkinos
Journal:  Exp Clin Cardiol       Date:  2003

Review 6.  Protection of the abnormal heart.

Authors:  Constantinos Pantos; Iordanis Mourouzis; Dennis V Cokkinos
Journal:  Heart Fail Rev       Date:  2007-12       Impact factor: 4.214

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.